摘要
目的 研究分析美托洛尔联合曲美他嗪治疗冠心病心力衰竭的临床效果。方法整群选取2013年3月—2015年3月该院收治的冠心病心力衰竭患者82例,分为两组,每组41例。对照组行常规治疗,观察组给予美托洛尔联合曲美他嗪治疗。对比两组患者治疗效果及心率、左心射血分数(LVEF)。结果观察组总有效率为97.56%高于对照组78.05%,差异有统计学意义(P<0.01);治疗后,观察组心率为(90.6±7.2)次/min、LVEF为(50.5±3.5)%,均优于对照组,差异有统计学意义(P<0.01)。结论美托洛尔联合曲美他嗪治疗冠心病心力衰竭可改善心功能,值得推广。
Objective To research and analyze the clinical effect of metoprolol combined with trimetazidine in treatment of coronary heart disease and heart failure. Methods 82 cases of patients with coronary heart disease and heart failure treated from March 2013 to March 2015 were selected and divided into two groups with 41 cases in each, the control group were treated with conventional method, the observation group were treated with metoprolol combined with trimetazidine, the treatment effect, heart rate and left ventricular ejection fraction（LVEF）of the two groups were compared. Results The total effective rate in the observation group was higher than that in the control group,（97.56% vs 78.05%）,and the difference was obvious（P〈0.01）, after treatment, the heart rate and LVEF were respectively（90.6±7.2）times/min and（50.5±3.5）%, which were better than those in the control group, and the differences were obvious（P0.01）. Conclusion Metoprolol combined with trimetazidine in treatment of coronary heart disease and heart failure can improve the heart function, which is worth promoting.
出处
《中外医疗》
2016年第7期107-108,共2页
China & Foreign Medical Treatment
关键词
美托洛尔
曲美他嗪
冠心病心力衰竭
Metoprolol
trimetazidine
coronary heart disease and heart failure
